Example OneDrug Combinations Accelerating Drug Development with Advanced Analytics More Information Example OneClinical Responder Analysis Accelerating Drug Development with Advanced Analytics More Information Example OneIndication Expansion Accelerating Drug Development with Advanced Analytics More Information

SlideBioXplor has developed a proprietary biomedical data platform and product suite of tools and algorithms for clinical responder analysis, drug combinations and indication expansion. Learn more Clinical Responders Drug Combinations Learn more Indication Expansion Learn more

Slide Drug Combinations for Severe Cytokine Storm in COVID-19 Novel Pathway Discovery & Drug Combinations for Lipedema Secukinumab versus Etanercept Study on Responders & Adverse Events Indication Expansion for a Phase 3 Drug Trial Failure Pancreatic Cancer Pathway & Biomarker Study PDL1 Biomarker Signature Study for Assay Design ETP-Acute Lymphoid Leukemia Novel Drug Combinations Case Studies

Slide Our clients include top tier pharmaceutical companies including Amgen, Novartis, Bayer and Merck. BioXplor leverages it's platform to analyse clinical and biomedical data for clinical responders, drug combinations and indication expansion. The network pharmacology data platform works by generating obvious and non-obvious knowledge on patients, drugs and diseases from structured and unstructured data using proprietary natural language processing and machine learning algorithms. Partnerships

Partners